<DOC>
	<DOCNO>NCT01435941</DOCNO>
	<brief_summary>Chronic Migraine ( CM ) , 15 migraine headache per month , common tertiary headache care associate number deleterious outcome , especially high disability poor quality life , relative Episodic Migraine ( EM ) define 14 few migraine headache per month . Limited work begin examine factor increase decrease risk develop CM . One factor appear especially relevant symptomatic medication use . The current study build upon expands previous work consider influence non-steroidal anti-inflammatory drug ( NSAID ) and/or triptan use likelihood develop CM . This study retrospective observational cohort study data collect via mail survey collate American Migraine Prevalence Prevention ( AMPP ) database . Survey result AMPP study analyze retrospectively . The AMPP longitudinal , population-based , mailed-questionnaire survey . In 2004 , 120,000 United States ( US ) household screen 24,000 individual report severe headache identify additional questionnaire administer annually . This analysis use data respondent meet second edition International Headache Classification-2 ( IHCD-2 ) criterion EM 2005 follow result 2006 , 2007 , 2008 , 2009 . EM define 1 14 headache per month CM define 15 headache per month .</brief_summary>
	<brief_title>Non-steroidal Anti-inflammatory Drugs Alone With Triptan Reports Transition From Episodic Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Respondents age 18 old time survey completion Respondents complete questionnaire 2004 least one year ( 2005 , 2006 , 2007 , 2008 , 2009 ) Based respondent answer 2004 survey , symptoms meet criterion EM characterize headache meet International Classification Headache Disorders 2 ( ICHD2 ) criteria migraine 114 day month Responses question suggest respondent 's diagnosis migraine CM</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>mail survey</keyword>
	<keyword>non-steroidal anti-inflammatory drug</keyword>
	<keyword>migraine disorder</keyword>
	<keyword>headache</keyword>
</DOC>